Europe — EMA
Nuvaring (Ethinylestradiol, Etonogestrel)
Ethinylestradiol, the active ingredient in Nuvaring, is a combined estrogen-progestogen contraceptive presented as a vaginal ring for transdermal use. It prevents pregnancy in women of reproductive age.
Request sourcing
What is Ethinylestradiol, Etonogestrel?
Ethinylestradiol, the active ingredient in Nuvaring, is a combined estrogen-progestogen contraceptive presented as a vaginal ring for transdermal use. It prevents pregnancy in women of reproductive age. GNH USA supplies Nuvaring as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Nuvaring as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Ethinylestradiol, Etonogestrel used for?
Nuvaring is a combined hormonal contraceptive that works on the reproductive endocrine pathway to prevent ovulation.
- Contraception: Provides effective, reversible birth control for women seeking a non‑daily method. - Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding patterns. - Acne management: May improve acne associated with hormonal fluctuations. - Endometriosis symptom relief: Reduces pelvic pain linked to endometrial tissue growth. - Hormone replacement therapy adjunct: Used alongside other hormones in certain post‑menopausal protocols. -
What are the side effects of Ethinylestradiol, Etonogestrel?
The
Common
-
